{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:31:53Z","timestamp":1757705513298},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"suppl C","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Heart Journal"],"published-print":{"date-parts":[[1997,5,2]]},"DOI":"10.1093\/eurheartj\/18.suppl_c.40","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T17:44:55Z","timestamp":1334857495000},"page":"40-44","source":"Crossref","is-referenced-by-count":6,"title":["Avoiding drug problems: The safety of drugs for supraventricular tachycardia"],"prefix":"10.1093","volume":"18","author":[{"given":"S. C.","family":"Reimold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/18\/suppl_C\/40\/1235224\/18-suppl_C-40.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:25:36Z","timestamp":1503447936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/18.suppl_C.40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5,2]]},"references-count":0,"journal-issue":{"issue":"suppl C","published-print":{"date-parts":[[1997,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/18.suppl_c.40","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,5,2]]}}}